Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS
TherapeuticsMD Inc. logo

TherapeuticsMD Inc.

Sector: Healthcare   

Industry: Drug Manufacturers - Major

1.88
 
USD
  
-0.01
  
(-0.79%)
Optionable: Yes  Market Cap: 22 M  90-day average vol: 23,166

Previous close: 1.895  Open: 1.9  Bid: 1.88  Ask: 1.96
52 week range    
1.84   
   4.73
Peers   
AGRX / 
LCI / 
RPRX / 
PFE / 
Last updated: Monday 6th May 2024

Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS

Get started today
Search for a stock

🎉 Exciting news! 🎉

You are invited to join our Discord Channel.

Interact, learn, and grow with experts in the markets!

Join our Discord

Financials

TXMD Cash Flow

Annual
Dec-13Dec-14Dec-15Dec-16Dec-17Dec-18Dec-19Dec-20Dec-21Dec-22
(Increase) Decrease in inventories571592.0-138495.0491960.0-386168.0-409037.0-2 M-9 M-3 M-711000.0
(Increase) Decrease in other current assets-2 M642972.0-790974.0709907.0-4 M-3 M
(Increase) Decrease in other current liabilities307760.0-840517.03 M84559.02 M9 M14 M
(Increase) Decrease in other working capital-2 M-220000.02 M-8 M
(Increase) Decrease in payables472851.04 M-3 M4 M-3 M19 M-4 M-2 M-1 M-1 M
(Increase) Decrease in receivables-1 M-458028.0-917656.0-4 M167691.0-7 M-14 M-8 M-4 M
Amortization of intangibles10262.023480.032441.054545.071516.0112474.0976285.03 M
AssetImpairmentCharge-15493.0-5436.022157.03 M4206.0216022.0386302.0-1 M-533000.0
CapitalExpenditureReported479824.0617442.0584361.01 M827108.01 M4 M2 M2 M355000.0
Cash at beginning of period2 M54 M51 M65 M132 M127 M162 M161 M80 M79 M
Cash at end of period54 M51 M65 M132 M127 M162 M161 M80 M79 M65 M
Cash flow-21 M-46 M-79 M-69 M-76 M-107 M-166 M-220 M-228 M121 M
Cash from disc. investing activities224 M
CashFlowFromContinuingInvestingActivities-583561.0-606756.0-584361.0-1 M-827108.0-21 M-24 M-2 M-2 M-355000.0
CashFromDiscontinuedOperatingActivities-181 M97 M
ChangeInAccountPayable472851.04 M-3 M4 M-3 M19 M-4 M-2 M-1 M-1 M
ChangeInAccruedExpense3 M239450.014 M3 M5 M4 M
ChangeInInterestPayable3 M239450.0
ChangeInPayablesAndAccruedExpense3 M4 M-3 M4 M-3 M19 M10 M-2 M4 M3 M
ChangeInPrepaidAssets3 M-1 M620000.0
ChangeInWorkingCapital1 M3 M-1 M664745.0-6 M16 M-14 M-10 M5 M-4 M
ChangesInAccountReceivables-1 M-458028.0-917656.0-4 M167691.0-7 M-14 M-8 M-4 M
Depreciation47883.028987.029959.077906.0141601.0181412.0415193.0-4 M736000.01 M
Depreciation unreconciled3 M312494.062400.0132451.0213117.0563745.02 M-4 M736000.01 M
DepreciationAndAmortization3 M312494.062400.0132451.0213117.0563745.02 M-4 M736000.01 M
FinancingCashFlow74 M43 M93 M137 M73 M163 M189 M81 M130 M-235 M
Free cash flow-21 M-46 M-80 M-70 M-77 M-108 M-170 M-161 M-57 M9 M
InterestPaidSupplementalData212853.02 M18 M26 M25 M14 M
Issuance of capital stock79 M43 M91 M135 M69 M90 M77 M32 M184 M2 M
Issuance of debt-5 M118 M50 M
IssuanceOfCapitalStock79 M43 M91 M135 M69 M90 M77 M32 M184 M2 M
IssuanceOfDebt-5 M75 M118 M47 M-50 M-219 M
Net cash from financing activities74 M43 M93 M137 M73 M163 M189 M78 M130 M-235 M
Net cash from investing activities-583561.0-606756.0-584361.0-1 M-827108.0-21 M-24 M-2 M-2 M-355000.0
Net cash from operating activities-21 M-46 M-79 M-69 M-76 M-107 M-166 M-159 M-55 M9 M
Net change in cash & cash equivalents53 M-3 M13 M67 M-4 M34 M-783364.0-80 M-15 M-16 M
Net income from continuing operations-28 M-54 M-85 M-90 M-77 M-133 M-176 M-184 M-252 M113 M
NetCommonStockIssuance79 M43 M91 M135 M69 M90 M77 M32 M184 M2 M
NetIntangiblesPurchaseAndSale-439034.0-586480.0-419104.0-845266.0-765291.0-1 M-1 M-1 M-2 M-355000.0
NetInvestmentPropertiesPurchaseAndSale-103737.010686.0-14036.0-20 M-20 M
NetInvestmentPurchaseAndSale-103737.010686.0-14036.0-20 M-20 M
NetIssuancePaymentsOfDebt-5 M75 M118 M47 M-50 M-219 M
NetLongTermDebtIssuance2944.075 M-82 M-3 M-50 M-219 M
NetPPEPurchaseAndSale-40790.0-30962.0-165257.0-396154.0-61817.0-217040.0-2 M-207000.0-34000.0
NetPreferredStockIssuance-17 M
Operating (gains) losses10 M-354000.0
Other financing charges net233000.0367000.0
Other investing changes net10686.0-14036.0-20 M-20 M
Other non-cash items4 M5 M7 M20 M7 M9 M12 M-22 M19 M12 M
PreferredStockIssuance22 M
PreferredStockPayments-39 M
ProceedsFromIssuanceOfWarrants181000.0366000.01 M4 M
ProceedsFromStockOptionExercised30910.0345746.01 M989060.0212615.02 M108656.0272000.0322000.0
Purchase of Float term investments-103737.010686.0
Purchase of property plant & equipment-479824.0-617442.0-584361.0-1 M-827108.0-1 M-4 M-2 M-2 M-355000.0
Purchase of short term investments2944.075 M-3 M-6 M
PurchaseOfIntangibles-439034.0-586480.0-419104.0-845266.0-765291.0-1 M-1 M-1 M-2 M-355000.0
PurchaseOfInvestment-103737.010686.0
PurchaseOfPPE-40790.0-30962.0-165257.0-396154.0-61817.0-217040.0-2 M-207000.0-34000.0
Repayment of debt-82 M-50 M-219 M
RepaymentOfDebt-5 M-82 M-50 M-219 M
Revenue per share3 M283507.032441.054545.071516.0382333.02 M6 M
ShortTermDebtIssuance500000.0200 M50 M
ShortTermDebtPayments-5 M-82 M
StockBasedCompensation4 M5 M7 M17 M7 M9 M11 M-11 M18 M12 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.

MarketXLS is a complete Excel stock solution

Kevin Hsu

StockKevin.com

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel

Lloyd Lenase

Option Day Trader

MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.

Dave

Swing trader since 2011

I like to access historical closing prices on a particular date. That makes tracking performance easy.

Patrick Cusatis, Ph.D., CFA

Associate Professor of Finance - Penn State University